BTG2016 Scientific Agenda

DAY 1: Feb 27, 2016

TIME
8:00 AM


8:30 AM -10:30 AM











10:30 AM - 11:00 AM
11:00 AM - 12:30 PM




12:30 PM - 2:00 PM
SESSION
Opening Remarks
APHCON Update
Integration of digital technology to leapfrog APHCON 
Acute Myeloid Leukemia: Best of 2015 (CME Session)

Ideal induction therapy for newly diagnosed AML. Do we have a consensus?    
Is it time to consider targeted therapy in combination for newly diagnosed AML? 
Ideal induction regimen for AML in adolescents and young adults    
Allogeneic stem cell transplant in CR1 for AML    
Elderly AML
Cellular Therapy in AML
Long term survival outcomes of APL. How will we treat APL in the future?
COFFEE BREAK/ EXHIBIT BOOTHS/ POSTER REVIEW
Acute Lymphocytic Leukemia: Best of 2014 (CME Session)
Advances in induction in ALL
Novel Immunotherapeutics in ALL
Cellular therapies in ALL
Personalized therapy in Pediatric ALL 
SPEAKER
Morton Coleman
Xiao Jun Huang
Simrit Parmar
Chair: JianXiang Wang and EJ Shpall

Vikram Mathews

Steven Kornblau

Swami Iyer
XJ Huang
Miguel A Sanz
Richard Champlin
Jiong Hu


Chair: Dei Pei Wu and Pankaj Malhotra
Raymond Wong
David Ritchie
EJ Shpall
Allen Yeoh
LUNCH SESSION

2:00 PM - 3:30 PM

SIMULTANEOUS WORKSHOPS
WORKSHOP-I
APLASTIC ANEMIA
Chair: Surapol Issaragrisil
Non-Transplant Therapies

Transplant Updates on donor and conditioning

Infectious Complications 
Zonghong Shao

Seiji Kojima



Vikram Mathews
WORKSHOP-II
CELLULAR THERAPY
Chair: L Zhang
Chimeric Antigen Receptor-T cells

Donor Lymphocyte Infusion

NK Cell Therapy

Regulatory T cells
Keiya Ozawa


Chenghua Yan


Akihiro Shimosaka
Simrit Parmar
WORKSHOP-III
THALASSEMIA
Chair: Borje Andersson
Chelation Update

Novel treatments: 

Transplant Updates 
Raymond Wong
Pankaj  Malhotra
Suradej Hongeng

3:30 PM - 4:00 PM

4:00 PM - 5:00 PM

COFFEE BREAK/ EXHIBIT BOOTHS/ POSTER REVIEW

SIMULTANEOUS WORKSHOPS
WORKSHOP-IV
Chronic Myelogenous Leukemia
Chair: ADLF Burguera and Qian Jiang
Imatinib vs. 2nd gen TKI in newly diagnosed CML 

Relapsed chronic CML: new players in targeted therapy

Second Malignancies in TKI treated CML

Defining goals for molecular remission in CML

When to stop TKI in CML?
Dong Wook Kim

Qin Yazhen


Pankaj Malhotra

Swami Iyer


David Ritchie
WORKSHOP-V
Myeloproliferative disorders
Chair: Ginna Laport
Revised classification/ prognostication

Treatment of High Risk Myelofibrosis

Allogeneic transplants for myelofibrosis:
Ideal induction and timing

Recent advances in treatment of MDS
Raymond Wong

Steve Kornblau

Borje Andersson



Zhijian Xiao
WORKSHOP-VI
Donor Selection
Chair: Deipei Wu
Haploidentical

Unrelated

Cord Blood

Sibling
Yu Wang

R Champlin

EJ Shpall

Miguel A Sanz

APHCON PRESIDENT RECEPTION AND TMG AWARD CEREMONY

Day 2: Feb 28, 2016

TIME
8:00 AM - 9:30 AM





9:30 AM - 10:00 AM
SESSION
MULTIPLE MYELOMA: Best of 2015 (CME Session)
Recent updates on targeted therapies in Myeloma
Optimal induction in Myeloma: Doublet vs. Triplet
Maintenance therapy in Myeloma
Timing for transplant in Myeloma


ORAL ABSTRACT PRESENTATION
SPEAKER
Chair: Jian Hou and David Ritchie
Robert Orlowski
James Chim
Jian Hou
Ginna Laport

10:00 AM - 10:30 AM

COFFEE BREAK/ EXHIBIT BOOTH/ POSTER VIEWING
10:30 AM - 11:30 AM





11:30 AM - 12:00 PM
LYMPHOMA: Best of 2014 (CME Session)
Targeting PD-1 and CD30 in Hodgkin’s Lymphoma 
Novel targeted therapies in Non Hodgkin’s B-cell Lymphoma
Novel targeted therapies in T-cell Lymphoma
Breakthroughs in CLL

KIAN ANG MEMORIAL LECTURE:
Nurse’s Role in the Interprofessional Team Caring for the Hematologic Malignancy Patient
Chair: Swami Iyer & Kaiyan Liu
Frederick Hagemeister
Sattva Neelapu
Jason Westin
Stephen Mulligan

Chair: Simrit Parmar
Joyce Neumann
12:00 PM- 2:00 PM



2:00 PM - 3:30 PM

LUNCH SESSION

SIMULTANEOUS WORKSHOPS
WORKSHOP VII
Chronic Lymphocytic Leukemia
Chair:  Deipei Wu
First Line Therapy in CLL

Novel targeted therapies in CLL

Relapsed Refractory CLL

Allogeneic stem cell transplant and cellular therapies in CLL

Maintenance therapy in CLL
Stephen Mulligan

Steve Kornblau

JianYong Li


EJ Shpall



Swami Iyer
WORKSHOP VIII
Large Cell Lymphoma
Chair: Daryl Tan
Classification and new prognostic factors

Biologic agents for Aggressive Lymphoma 

Relapsed Large Cell Lymphoma
Eric Davis


Sattva Neelapu


Jason Westin
WORKSHOP IX
Virus associated Lymphoma 
Chair: M Wang
PTLD-EBV Lymphoma

HIV-Lymphoma (NHL and HL)

Burkitt’s Lymphoma- EBV

NK-T cell Lymphoma (EBV)
Frederick Hagemeister

Ginna Laport


Jason Westin


Daobin Zhou
3:30 PM - 4:00 PM
4:00 PM - 5:00 PM
COFFEE BREAK/ EXHIBIT BOOTH/ POSTER VIEWING
SIMULTANEOUS WORKSHOPS
WORKSHOP X
Indolent Lymphoma
Chair: Kaiyan Liu
Follicular Lymphoma

Timing of Transplant for Indolent Lymphomas

Transformed Indolent Lymphoma

Mantle Cell Lymphoma
Daryl Tan

Ginna Laport



Daobin Zhou

M Wang
WORKSHOP XI
Targeted Therapy in Lymphoma
Chair: Pankaj Malhotra
Ibrutinib

Idelalisib

Obinutuzumab


Romidepsin
Michael Wang

Sattva Neelapu

Frederick Hagemeister

Jason Westin
WORKSHOP XII
Multiple Myeloma
Chair: James Chim
When to trigger second line treatment?

Optimal therapy for relapsed myeloma: maximize initial agent or switch to new regimen? 

New triplet regimens in relapsed Myeloma: 

Elderly Myeloma: 
Yu Hu


David Ritchie




Raymond Wong

Robert Orlowski